6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!
Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort Study.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2021 – May 2025Where it's discussed
-
News70 articles
-
Facebook17 posts
-
Blogs6 articles
-
X / Twitter5 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions support the importance of the study by citing how stopping statins can lead to worse health outcomes, with posts like 'stopping statins leads to increased mortality.' At the same time, there are cautious responses criticizing the interpretation of small percentage differences as significant, indicating a balance of agreement with and skepticism toward the study's conclusions based on the tone and focus of the comments.
Most discussions highlight the importance of continuing statins after adverse reactions, emphasizing their role in reducing mortality and cardiovascular issues.
The topic of statin continuation and its implications naturally draws moderate interest, reflected in concerns about medical decisions and patient outcomes.
Posts show some engagement by referencing the significance of the study, but limited detailed discussion or critique is present.
Participants recognize the potential impact of the findings on clinical practices, though skepticism about the interpretation of statistical significance tempers full enthusiasm.
Abstract in brief
- The study found that patients who continued statin therapy after experiencing adverse reactions had a slightly lower risk (17% reduction) of cardiovascular events or death over four years compared to those who stopped using statins.
- Most adverse reactions were identified through provider notes, and it was unclear if patients always took the medication as prescribed.
- Continued statin use after adverse reactions was linked to better patient outcomes, but the actual risk of having more adverse reactions upon reusing statins could not be determined from the data.]
Top posts
Most liked on X and BlueskyOtro ejemplo de una publicación "científica" en el cual interpretan que una diferencia del 1 o 2 % entre el grupo medicado y el no medicado es significativa, cuando es mínima . Las conclusiones no están alineadas con los datos objetivos https://t.co/9GogcoFtuW
Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort Study https://t.co/fJLyXbsqZA
RT @CFAndersenMD: 6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!
All mentions
Understanding the Nocebo Effect and Its Impact on Healthcare Outcomes
This video explains the Nocebo Effect, its mechanisms, and its influence on patient outcomes. It discusses expectations, brain activity, and cases highlighting how negative perceptions can affect health, especially in…
Managing Statin Use: When and How to Taper Off Safely
I am often asked if one can get off statins cold turkey or if there is a better way such as tapering off. This video offers insights into safely stopping statin therapy and discusses the experiences of physicians with…
Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort Study https://t.co/fJLyXbsqZA
RT @CFAndersenMD: 6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!
6/ Why does it matter? Well, stopping statins leads to increased mortality and worse CV outcomes!
RT @Soly_1984: Otro ejemplo de una publicación "científica" en el cual interpretan que una diferencia del 1 o 2 % entre el grupo medicado y…
Otro ejemplo de una publicación "científica" en el cual interpretan que una diferencia del 1 o 2 % entre el grupo medicado y el no medicado es significativa, cuando es mínima . Las conclusiones no están alineadas con los datos objetivos https://t.co/9GogcoFtuW
CM
S
JF
C
BA